Literature DB >> 2902761

The somatostatin/histaminic pathway balance on gastric secretion could be based on a competitive antagonism.

J Vatier1, C Poitevin, W Riquet, M T Vitre, A Olivier, P Martin, S Bonfils.   

Abstract

Measurements of acid and pepsin secretions and of histamine release in response to food alone or in combination with graded doses of antramine (AH), a molecular form of histamine isolated from antral mucosa, with or without somatostatin were performed simultaneously in dogs equipped with a denervated pouch. AH restored somatostatin-inhibited acid and pepsin secretions but with different intensities in regard to the different inhibitory levels induced by somatostatin. AH competitively antagonized somatostatin (1 microgram/kg/h) inhibition of acid secretion, but when stronger levels of inhibition were achieved, AH restored weakly acid secretion. Recovery of pepsin secretion occurred through a competitive mechanism between AH and somatostatin (1 and 2 micrograms/kg/h). There was a close relationship between the secretory outputs and the integrated histamine responses; the slopes of the regression lines might be considered as reflecting the stimulatory activity of blood histamine on secreting cells. For acid secretion, this activity is similar in control and somatostatin (1 microgram/kg/h) tests, while for pepsin secretion it is identical in control and 1 or 2 micrograms/kg/h somatostatin tests. One can speculate that the suppression of the somatostatin inhibitory effects by antramine, within the limits of physiological conditions, results from a competitive mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902761     DOI: 10.1007/bf02028278

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  26 in total

1.  The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass.

Authors:  W I CARD; I N MARKS
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

2.  Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; J Swierczek; N Kwiecień; E Mikoś; J Oleksy; Z Wierzbicki
Journal:  Am J Dig Dis       Date:  1977-11

3.  Inhibitory effect of somatostatin on gastric acid secretion and serum gastrin in dogs with and without duodenogastric reflux.

Authors:  W E Thomas
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

4.  Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs.

Authors:  A A Barros D'Sa; S R Bloom; J H Baron
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

5.  A sensitive and specific method for the determination of histomine in human whole blood and plasma.

Authors:  W Lorenz; H J Reimann; H Barth; J Kusche; R Meyer; A Doenicke; M Hutzel
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-06

6.  Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.

Authors:  S J Konturek; J Tasler; M Cieszkowski; D H Coy; A V Schally
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

7.  Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.

Authors:  A A Barros D'sa; S R Bloom; J H Baron
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

8.  Somatostatin mode of action on gastric acid secretion in dogs.

Authors:  H Hummelt; H M Jennewein; R Treichel; F Waldeck
Journal:  Digestion       Date:  1977-02       Impact factor: 3.216

9.  Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin.

Authors:  D H Stern; J H Walsh
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

10.  Gastric acid secretion results from antagonistic effects of antral histamine (Antramine) and somatostatin on gastrin.

Authors:  J Vatier; C Poitevin; J C Robert; M T Vitre; B K Nguyen Phuoc; S Bonfils
Journal:  Agents Actions       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.